Competing risks of antiepileptic drug failure: Importance, measurement and analysis

被引：0
|
作者：
Williamson, P.
Smith, C. Tudur
Sander, J.
Marson, A.
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] UCL, London, England
来源：
EPILEPSIA | 2006年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] COMPETING RISKS IN MORTALITY ANALYSIS
    CHIANG, CL
    ANNUAL REVIEW OF PUBLIC HEALTH, 1991, 12 : 281 - 307
  • [32] Interpretability and importance of functionals in competing risks and multistate models
    Andersen, Per Kragh
    Keiding, Niels
    STATISTICS IN MEDICINE, 2012, 31 (11-12) : 1074 - 1088
  • [33] An Introduction to Competing Risks Analysis
    Pintilie, Melania
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (07): : 599 - 605
  • [34] Semiparametric competing risks analysis
    Canals-Cerda, Jose
    Gurmu, Shiferaw
    ECONOMETRICS JOURNAL, 2007, 10 (02): : 193 - 215
  • [35] Regression analysis of competing risks data with general missing pattern in failure types
    Dewanji, Anup
    Sankaran, P. G.
    Sengupta, Debasis
    Karmakar, Bappa
    STATISTICAL METHODOLOGY, 2016, 29 : 18 - 31
  • [36] The Impact of Obesity on Allograft Failure After Kidney Transplantation: A Competing Risks Analysis
    Naik, Abhijit S.
    Sakhuja, Ankit
    Cibrik, Diane M.
    Ojo, Akinlolu O.
    Samaniego-Picota, Milagros D.
    Lentine, Krista L.
    TRANSPLANTATION, 2016, 100 (09) : 1963 - 1969
  • [37] An approach to joint analysis of longitudinal measurements and competing risks failure time data
    Elashoff, Robert M.
    Li, Gang
    Li, Ning
    STATISTICS IN MEDICINE, 2007, 26 (14) : 2813 - 2835
  • [38] Analysis of competing risks survival data when some failure types are missing
    Goetghebeur, E
    Ryan, L
    BIOMETRIKA, 1995, 82 (04) : 821 - 833
  • [39] Incorporating classification uncertainty in competing-risks nest-failure analysis
    Etterson, Matthew A.
    Stanley, Thomas R.
    AUK, 2008, 125 (03): : 687 - 699
  • [40] Optimisation of antiepileptic drug therapy - The importance of serum drug concentration monitoring
    Yukawa, E
    CLINICAL PHARMACOKINETICS, 1996, 31 (02) : 120 - 130
12345